Skip to main content
SERA PROGNOSTICS, INC. logo

SERA PROGNOSTICS, INC. — Investor Relations & Filings

Ticker · SERA ISIN · US81749D1072 US Manufacturing
Filings indexed 558 across all filing types
Latest filing 2026-05-06 Interim / Quarterly Rep…
Country US United States of America
Listing US SERA

About SERA PROGNOSTICS, INC.

https://www.sera.com/

Sera Prognostics, Inc., also known as 'The Pregnancy Company®', is a health diagnostics company focused on improving maternal and infant health through precision pregnancy care. The company's flagship product is the PreTRM® Test, a first-of-its-kind biomarker blood test designed to predict the individual risk of spontaneous preterm birth in asymptomatic women with singleton pregnancies. The test is administered via a single blood draw during the 18th to 20th week of gestation, providing pivotal information to physicians for proactive management. Sera Prognostics also offers the LikeMine™ platform, which uses data from millions of pregnancies to offer comparative insights. The company aims to deliver high-value diagnostics to providers, mothers, payers, and employers to improve health outcomes and reduce healthcare costs associated with premature birth.

Recent filings

Filing Released Lang Actions
10-Q - SERA PROGNOSTICS, INC. (0001534969) (Filer)
Interim / Quarterly Report
2026-05-06 English
10-K - SERA PROGNOSTICS, INC. (0001534969) (Filer)
Annual Report FY 2025
2026-03-18 English
4 - SERA PROGNOSTICS, INC. (0001534969) (Filer)
Director's Dealing
2026-02-25 English
4 Filing
Director's Dealing
2026-02-04 English
4 Filing
Director's Dealing
2026-01-27 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-01-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.